These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 807702)

  • 41. [Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats].
    Huo ZL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Mar; 9(2):118-20, 159. PubMed ID: 8221304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
    Boekema BK; Pool L; Ulrich MM
    Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silver sulfadiazine and Sulfamylon cream in the burned rat model: a comparative evaluation.
    Dressler DP; Skornik WA
    Surgery; 1970 Apr; 67(4):644-9. PubMed ID: 5435914
    [No Abstract]   [Full Text] [Related]  

  • 44. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of prophylaxis by silver compounds against infection of burns.
    Ricketts CR; Lowbury EJ; Lawrence JC; Hall M; Wilkins MD
    Br Med J; 1970 May; 1(5707):444-6. PubMed ID: 4986877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternate case study of topical sulfamylon and silver sulfadiazine in burns.
    Ollstein RN; Symonds FC; Crikelair GF; Pelle L
    Plast Reconstr Surg; 1971 Oct; 48(4):311-7. PubMed ID: 5097738
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy of pseudomonas septicaemia in burned mice: systemic therapy with streptomycin and sulphonamides.
    Rosenthal SM
    Br J Pharmacol Chemother; 1968 Jul; 33(3):537-43. PubMed ID: 4973762
    [No Abstract]   [Full Text] [Related]  

  • 50. Sliver sulfadiazine.
    Med Lett Drugs Ther; 1974 May; 16(10):43-4. PubMed ID: 4830298
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
    Ballin JC
    JAMA; 1974 Nov; 230(8):1184-5. PubMed ID: 4479596
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine.
    Kuroyanagi Y; Kim E; Shioya N
    J Burn Care Rehabil; 1991; 12(2):106-15. PubMed ID: 1904876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis.
    Vasishta R; Saxena M; Chhibber S
    Folia Microbiol (Praha); 1991; 36(5):498-501. PubMed ID: 1821876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
    Alexander JW; Fisher MW; MacMillan BG
    Arch Surg; 1971 Jan; 102(1):31-5. PubMed ID: 4992359
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment.
    Akhoondinasab MR; Khodarahmi A; Akhoondinasab M; Saberi M; Iranpour M
    Burns; 2015 Feb; 41(1):125-31. PubMed ID: 24907191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local and systemic therapy of pseudomonas septicemia in burned mice.
    Rosenthal SM
    Ann Surg; 1967 Jan; 165(1):97-103. PubMed ID: 4289482
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of pyridonic acid derivatives as topical antibiotics on the prevention and treatment of pyocyaneous infection following burn].
    Ge SD
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Mar; 3(1):10-3. PubMed ID: 3151855
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of phosphate supplementation on Pseudomonas aeruginosa invasive behavior in burn wound infections: A simple approach to a big problem.
    Mohammadi-Samani S; Kouroshfard S; Azarpira N
    Burns; 2016 Mar; 42(2):428-33. PubMed ID: 26787129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental study on topical antimicrobial agents in burns.
    Ge SD; Hu ZL; Cheng YL; Fang ZY; Tu SZ; Xu BR; Jiang XT
    Burns Incl Therm Inj; 1987 Aug; 13(4):277-80. PubMed ID: 3664316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.